Pure Global
NCT06412237

An Exploratory Study of a Wearable Robotic Hand Orthosis

An Exploratory Study of a Wearable Robotic Hand Orthosis in the Chronic Stroke Population in Singapore: A Clinic to Home Feasibility Trial
Tan Tock Seng Hospital·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Stroke
Drug/Device/Intervention
RELab tenoexo
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Tan Tock Seng Hospital
Location
Singapore, Singapore
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Dec 01, 2024
Enrollment
20 participants
Primary outcome

Action Research Arm Test (ARAT) Score

Summary

Upper limb deficits usually remain in 75% of the stroke survivors despite completing full
 rehabilitation. This is due to lack of effectiveness of rehabilitation and the degree of
 support and resources available.
 
 In this study, the investigators plan to study the use of assistive technologies in chronic
 stroke survivors.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionFamily history of strokeCerebral infarction, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06412237
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06412237 through Pure Global AI's free database. This phase not specified trial is sponsored by Tan Tock Seng Hospital and is currently Not yet recruiting. The study focuses on Stroke. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.